/
/
/

Cohance Lifesciences Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)463.30
Volume (₹)4.41 L
High (₹)470.00
Upper Circuit553.00
Low (₹)456.75
Lower Circuit368.70
Prev Close460.85
52W High (₹)1,038.90
Price457.75
52W Low (₹)266.70

Share Market Cap & Key Ratios Overview

M.Cap (₹)17605.20 Cr
Div. Yield (%)0.00
PE Ratio165.73
Debt to Equity0.04
Price to Book2.97
Book Value101.76
EPS (TTM)2.78
Face Value1.00
ROE (%)4.02

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
COHANCENSE
LTP
1W Low
1W High
Market cap (₹)
1901.4-18.6 (-0.97%)
1896.80
1984.80
4,56,833Cr
9158.5-80.5 (-0.87%)
9087
9467
2,45,426Cr
4843.5-206.5 (-4.09%)
4823
5066
1,87,320Cr
1129.5-61.5 (-5.16%)
1125.10
1187
1,13,217Cr
1380.9-42.6 (-2.99%)
1376
1426.10
1,12,212Cr
1845.1-93.4 (-4.82%)
1811.70
1949
1,01,155Cr
2113.9-57.6 (-2.65%)
2107.20
2192
97,626Cr
2331-51.9 (-2.18%)
2327.30
2419.20
96,859Cr
1158.6-19.4 (-1.65%)
1154.40
1179.90
96,406Cr
1651.5+6.2 (0.38%)
1622.60
1717
93,614Cr
457.8+7.9 (1.76%)
444
476.50
17,605Cr

Key Highlights of Cohance Lifesciences Ltd Balance Sheet

Cohance Lifesciences Ltd balance sheet discloses shareholders' funds of ₹38.26Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹38.26Cr, and the reserves and surplus of the company is ₹4423.77Cr.

The company has its non-current liabilities with total liabilities of ₹5113.2Cr as of 2026-03-31.

The current liabilities are ₹504.71Cr as of 2026-03-31. At the same time, current assets are ₹1668.67Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹925.26Cr and tangible assets of ₹2287.88Cr, provided in the Cohance Lifesciences Ltd financial statements.